An exploratory study to investigate the impact on the viral reservoir of adding a broadly neutralizing antibody with or without an attachment inhibitor to an integrase inhibitor-based antiretroviral therapy regimen in adults living with HIV (ENTRANCE)

2025-520629-19-00 Protocol 221794 Human pharmacology (Phase I) - Other Ongoing, recruitment ended

Start 1 Oct 2025 · Status Ongoing, recruitment ended · 4 EU/EEA countries · 25 sites · Protocol 221794

Overview

Sponsor-declared trial summary

Phase Human pharmacology (Phase I) - Other
Status Ongoing, recruitment ended
Participants planned 100
Countries 4
Sites 25

HIV Infections

Key facts

Sponsor
Viiv Healthcare UK Limited
Participant type
Patients
Age range
18-64 years, 65+ years
Gender
Male and Female
Therapeutic area
Diseases [C] - Virus Diseases [C02]
Trial duration
1 Oct 2025 → ongoing
Decision date (initial)
2025-09-23
Transition trial
No
Low-intervention
No
Rare-disease indication
No
Vulnerable population
No

Trial design

CTIS Part I — objectives, methods, condition coding

Conditions and MedDRA coding

HIV Infections

VersionLevelCodeTermSystem organ class
28.0 LLT 10068341 HIV-1 infection 10021881

Sponsors and contacts

Sponsor organisations, regulatory contacts, third parties

Viiv Healthcare UK Limited

Sponsor organisation
Viiv Healthcare UK Limited
Address
79 New Oxford Street
City
London
Postcode
WC1A 1DG
Country
United Kingdom

Scientific contact point

Organisation
Viiv Healthcare UK Limited
Contact name
EU GSK Clinical Trials Call Center

Public contact point

Organisation
Viiv Healthcare UK Limited
Contact name
EU GSK Clinical Trials Call Center

Locations

4 EU/EEA countries · 25 investigational sites

By country

CountryMS statusPlanned subjectsSites
Belgium Ongoing, recruitment ended 6 2
Denmark Ongoing, recruitment ended 6 2
Netherlands Ongoing, recruitment ended 3 1
Spain Ongoing, recruitment ended 57 20
Rest of world
United States, United Kingdom
28

Investigational sites

Belgium

2 sites · Ongoing, recruitment ended
Universitair Ziekenhuis Gent
Department of Internal Medicine, Corneel Heymanslaan 10, 9000, Gent
CHU Saint Pierre
Department of Internal Medicine, Hoogstraat 322, 1000, Brussels

Denmark

2 sites · Ongoing, recruitment ended
Region Midtjylland
Department of Infectious Diseases, Palle Juul-Jensens Boulevard 99, 8200, Aarhus N
Region Hovedstaden
Department of Infectious Diseases, Kettegaard Alle 30, 2650, Hvidovre

Netherlands

1 site · Ongoing, recruitment ended
Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)
Department of Internal Medicine, Wytemaweg 80, 3015 CN, Rotterdam

Spain

20 sites · Ongoing, recruitment ended
Hospital Universitario Fundacion Jimenez Diaz
Internal Medicine Service, Avenida De Los Reyes Catolicos 2, 28040, Madrid
University Hospital Virgen Del Rocio S.L.
Infectious diseases service, Avenida De Manuel Siurot S/n, 41013, Sevilla
Hospital Universitario Y Politecnico La Fe
Infectious diseases service, Avenida Fernando Abril Martorell 106, 46026, Valencia
Hospital Universitario Puerta De Hierro De Majadahonda
Internal medicine service, Calle De Manuel De Falla 1, 28222, Majadahonda
Hospital Universitario De Canarias
Infectious diseases service, Carretera Ofra S/N, 38320, San Cristobal De La Laguna
Hospital Del Mar
Infectious diseases service, Passeig Maritim De La Barceloneta 25-29, 08003, Barcelona
Hospital Universitario 12 De Octubre
Internal Medicine Service, Avenida De Cordoba Sn, 28041, Madrid
Hospital Universitari Vall D Hebron
Infectious diseases service, Passeig De La Vall D'Hebron 119-129, 08035, Barcelona
Hospital Universitario Reina Sofia
Infectious diseases service, Avenida Menendez Pidal S/n, 14004, Cordoba
Hospital Universitario Ramon Y Cajal
Infectious diseases service, Carretera Del Colmenar Viejo Km 9 100, Por El Pardo, Madrid
Hospital Universitario Infanta Leonor
Internal medicine service, Avenida Gran Via Del Este 80, 28031, Madrid
Hospital Son Llatzer
Internal medicine service, Carretera De Manacor Km 4, 07198, Palma
Hospital Germans Trias I Pujol
Infectious diseases service, Carretera Canyet 1a Planta, 08916, Badalona
Bellvitge University Hospital
Infectious diseases service, Carrer De La Feixa Llarga S/N, 08907, L'Hospitalet De Llobregat
Hospital De La Santa Creu I Sant Pau
Internal Medicine Service, Carrer De San Quinti 89, 08041, Barcelona
University Hospital Son Espases
Internal medicine service, Carretera Valldemossa 79, 07120, Palma
Hospital Clinic De Barcelona
Infectious diseases service, Calle Villarroel 170, 08036, Barcelona
Hospital Universitario La Paz
Internal Medicine Service, Paseo De La Castellana 261, 28046, Madrid
Consorcio Hospital General Universitario De Valencia
Infectious diseases service, Avenida Tres Cruces 2, 46014, Valencia
Hospital Clinico San Carlos
Infectious diseases service, Calle Del Profesor Martin Lagos Sn, 28040, Madrid

Country notifications

Trial-start, recruitment-start, end and early-termination notifications submitted per Member State

Country Trial startTrial end Recruitment startRecruitment end Early termination
Belgium 2025-11-13 2025-11-13 2026-01-19
Denmark 2025-10-24 2025-10-24 2026-01-26
Netherlands 2025-12-11 2025-12-11 2026-01-23
Spain 2025-10-01 2025-10-01 2026-01-26

Application history

5 submissions — initial application plus substantial / non-substantial modifications

#TypeCodeSubmittedReference MSConclusionDecision date
1 INITIAL IN 2025-05-30 Denmark Acceptable
2025-09-22
2025-09-22
2 SUBSTANTIAL MODIFICATION SM-1 2025-11-25 Acceptable 2026-01-14
3 NON SUBSTANTIAL MODIFICATION NSM-1 2026-01-14 2026-01-14
4 NON SUBSTANTIAL MODIFICATION NSM-2 2026-01-29 Denmark 2026-01-29
5 NON SUBSTANTIAL MODIFICATION NSM-3 2026-03-19 Denmark 2026-03-19